Impact of host restriction factors and capsid evolution on HIV disease progression by Boswell, M

Delayed disease progression in HIV-2: the importance of TRIM5α and the retroviral capsid by Boswell, M, Rowland-Jones, S

Targeting TRIM5 alpha in HIV cure strategies for the CRISPR-Cas9 era by Weatherley, D, Boswell, M, Rowland-Jones, S

Proton and deuteron F[subscript 2] structure function at low Q[superscript 2] by Tvaskis, V., Arrington, J., Asturyan, R., Baker, O. K., Blok, H. P., Bosted, P., Boswell, M., Bruell, A., Christy, M. E., Cochran, A., Ent, R., Filippone, Bradley W., Gasparian, A., Keppel, C. E., Kinney, E., Lapikas, L., Lorenson, W., Mack, D. J., Mammei, J., Martin, J. W., Mkrtchyan, H., Niculescu, I., Piercey, R. B., Potterveld, D. H., Smith, G., Spurlock, K., van der Steenhoven, G., Stepanyan, S., Tadevosian, V., Wood, S. A.

Get full text